UNITED STATES

 

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): October 25, 2012

 

Colfax Corporation

 

(Exact name of registrant as specified in its charter)

 

Delaware   001-34045   54-1887631
(State or other jurisdiction   (Commission   (I.R.S. Employer
of incorporation)   File Number)   Identification No.)

 

8170 Maple Lawn Boulevard, Suite 180

Fulton, MD 20759

(Address of Principal Executive Offices) (Zip Code)

 

(301) 323-9000

(Registrant’s telephone number, including area code)

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 

 

Item 2.02. Results of Operations and Financial Condition.

 

On October 25, 2012, Colfax Corporation issued a press release reporting financial results for the third quarter ended September 28, 2012. A copy of Colfax Corporation’s press release is attached to this report as Exhibit 99.1 and is incorporated in this report by reference. Colfax Corporation has scheduled a conference call for 8:00 a.m. EDT on October 25, 2012 to discuss its financial results, and slides for that call are attached to this report as Exhibit 99.2 and are incorporated in this report by reference.

 

 
 

 

Item 9.01. Financial Statements and Exhibits.

 

(d)Exhibits

 

99.1Colfax Corporation press release dated October 25, 2012, reporting financial results for the third quarter ended September 28, 2012.

 

99.2Colfax Corporation slides for October 25, 2012 conference call reporting financial results for the third quarter ended September 28, 2012.

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Colfax Corporation
     
Date: October 25, 2012 By: /s/ C. Scott Brannan
  Name: C. Scott Brannan
  Title:

Senior Vice President, Finance and Chief

Financial Officer

 

 
 

 

EXHIBIT INDEX

 

99.1 Colfax Corporation press release dated October 25, 2012, reporting financial results for the third quarter ended September 28, 2012.
   
99.2 Colfax Corporation slides for October 25, 2012 conference call reporting financial results for the third quarter ended September 28, 2012.

 

 

 

Colfax Reports Third Quarter 2012 Results

FULTON, Md., Oct. 25, 2012 /PRNewswire/ -- Colfax Corporation (NYSE: CFX) today announced its financial results for the third quarter of 2012. On a year-over-year basis, highlights for the third quarter and year-to-date period include:

Third Quarter of 2012 (all comparisons versus the third quarter of 2011)

  • After $14.5 million of pre-tax year-one acquisition-related amortization expense, net income of $4.0 million (4 cents per share); adjusted net income (as defined below) of $40.7 million (33 cents per share), which includes a non-cash 3 cents per share gain related to a discrete deferred tax benefit recorded
  • Net sales of $954.4 million, organic sales increase (as defined below) of 5.1% from third quarter 2011 proforma net sales (includes the comparable period sales for the operations acquired in the Charter acquisition)
  • Operating income of $51.7 million; adjusted operating income (as defined below) of $85.3 million
  • Third quarter gas- and fluid-handling orders of $443.8 million, an organic order increase (as defined below) of 4.0%
  • Gas- and fluid-handling backlog of $1.4 billion at period end

Nine Months Ended September 28, 2012 (all comparisons versus the nine months ended September 30, 2011)

  • After pre-tax expenses of $62.6 million of year-one acquisition-related amortization expense and $43.6 million of Charter acquisition-related expense, a net loss of $98.0 million ($1.09 per share); adjusted net income (as defined below) of $109.3 million (92 cents per share)
  • Net sales of $2.9 billion, an increase of 3.5% from the nine months ended September 30, 2011 proforma net sales (includes the comparable period sales for the operations acquired in the Charter acquisition); organic sales increase (as defined below) of 8.2%
  • Operating income of $87.8 million; adjusted operating income (as defined below) of $245.9 million 
  • Gas- and fluid-handling orders of $1.5 billion, an increase of 3.5%; organic order increase (as defined below) of 3.1%

Adjusted net income, adjusted net income per share, adjusted operating income, organic sales growth and organic order growth are not financial measures calculated in accordance with generally accepted accounting principles in the U.S. ("GAAP"). See below for a description of the measures' usefulness and a reconciliation of these measures to their most directly comparable GAAP financial measures.

Steve Simms, President and Chief Executive Officer, stated, "We are very pleased with the strong growth in our long cycle gas- and fluid-handling business, which increased revenues by 14.6% organically in comparison to the proforma 2011 third quarter. Volumes in our shorter cycle fabrication technology business were negatively impacted by the challenging global economic environment. However, despite the volume declines, we achieved improvement in adjusted operating margins through improved product pricing, aggressive SG&A restructuring, global sourcing and plant consolidations."

Non-GAAP Financial Measures and Other Adjustments

Colfax has provided in this press release financial information that has not been prepared in accordance with GAAP. These non-GAAP financial measures are adjusted net income, adjusted net income per share, adjusted operating income, organic sales growth and organic order growth. Adjusted net income, adjusted net income per share and adjusted operating income exclude asbestos coverage litigation expense, restructuring and other related charges, charges related to the Charter acquisition and fair value adjustments related to the ESAB and Howden inventory and backlog amortization expense to the extent they impact the periods presented. The effective tax rates used to calculate adjusted net income and adjusted net income per share are 25.3% and 29.0% for the third quarter and nine months ended September 28, 2012, respectively, and 31% for both the third quarter and nine months ended September 30, 2011. Proforma organic sales growth and proforma organic order growth represent the proforma comparison of the change in existing businesses that includes the operations acquired in the Charter Acquisition for the comparable prior period (which excludes the results of operations acquired in the Charter Acquisition for the first 12 days of each year to date reporting period) excluding the impact due to acquisitions made by Colfax and Charter and foreign currency fluctuations. These non-GAAP financial measures assist Colfax in comparing its operating performance on a consistent basis because, among other things, they remove the impact of asbestos coverage litigation, costs related to the Charter acquisition and foreign currency fluctuations outside the control of its operating management team.

Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information calculated in accordance with GAAP. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures. A reconciliation of non-GAAP financial measures presented above to GAAP results has been provided in the financial tables included in this press release.

Conference Call and Webcast

Colfax will host a conference call to provide details about its results on Thursday, October 25, 2012 at 8:00 a.m. EDT. The call will be open to the public through 877-303-7908 (U.S. callers) or 678-373-0875 (international callers) and referencing the conference ID number 43963077, or through webcast via Colfax's website at www.colfaxcorp.com under the "Investors" section. Access to a supplemental slide presentation can also be found at the Colfax website under the same heading. Both the audio of this call and the slide presentation will be archived on the website later today and will be available until the next quarterly call.

About Colfax Corporation

Colfax Corporation is a diversified global manufacturing and engineering company that provides gas- and fluid-handling and fabrication technology products and services to commercial and governmental customers around the world under the Howden, Colfax Fluid Handling and ESAB brands. Colfax believes that its brands are among the most highly recognized in each of the markets that it serves. Colfax is traded on the NYSE under the ticker "CFX." Additional information about Colfax is available at www.colfaxcorp.com.

CAUTIONARY NOTE CONCERNING FORWARD LOOKING STATEMENTS:

This press release may contain forward-looking statements, including forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning Colfax's plans, objectives, expectations and intentions and other statements that are not historical or current fact. Forward-looking statements are based on Colfax's current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause Colfax's results to differ materially from current expectations include, but are not limited to factors detailed in Colfax's reports filed with the U.S. Securities and Exchange Commission including its 2011 Annual Report on Form 10-K under the caption "Risk Factors." In addition, these statements are based on a number of assumptions that are subject to change. This press release speaks only as of the date hereof. Colfax disclaims any duty to update the information herein.

The term "Colfax" in reference to the activities described in this press release may mean one or more of Colfax's global operating subsidiaries and/or their internal business divisions and does not necessarily indicate activities engaged in by Colfax Corporation.

Colfax Corporation
Condensed Consolidated Statements of Operations
Dollars in thousands, except per share data
(Unaudited)



Three Months Ended

Nine Months Ended


September 28, 2012

September 30,
2
011

September 28,
2012

September 30,
2011

Net sales

$    954,440

$   170,294

$  2,886,459

$ 515,601

Cost of sales

666,453

109,667

2,041,904

337,046

Gross profit

287,987

60,627

844,555

178,555

Selling, general and administrative expense

217,143

41,074

661,191

123,376

Charter acquisition-related expense

5,728

43,617

5,728

Restructuring and other related charges

15,865

5,299

43,066

7,518

Asbestos coverage litigation expense

3,313

3,086

8,840

8,454

Operating income

51,666

5,440

87,841

33,479

Interest expense

23,557

1,218

68,280

4,507

Income before income taxes

28,109

4,222

19,561

28,972

Provision for income taxes(1)(2)

13,610

532

86,891

8,337

Net income (loss)

14,499

3,690

(67,330)

20,635

Less: net income attributable to noncontrolling interest,

net of taxes

5,405

 

16,808

 

Net income (loss) attributable to Colfax Corporation

9,094

3,690

(84,138)

20,635

Dividends on preferred stock

5,072

13,879

Net income (loss) available to Colfax Corporation common

 shareholders

$        4,022

$        3,690

$     (98,017)

$     20,635

Net income (loss) per share—basic and diluted

$          0.04

$          0.08

$         (1.09)

$         0.47

(1) Provision for income taxes the nine months ended September 28, 2012 was significantly impacted by the reassessment of certain deferred tax assets as of the date of the Charter acquisition, which resulted in an increase in the Company's valuation allowance, and the Charter acquisition-related expenses that are either not deductible for tax purposes or were incurred in jurisdictions where no tax benefit can be recognized.

(2) Income tax provision for the three and nine months ended September 28, 2012 includes a $2.9 million gain from a discrete deferred tax benefit recorded to reflect lower tax rates enacted in the United Kingdom during the third quarter.

Colfax Corporation
Reconciliation of GAAP to Non-GAAP Financial Measures
Dollars in thousands, except per share data
(Unaudited)



Three Months Ended

Nine Months Ended


September 28,

2012

September 30,

2011

September 28,

2012

September 30,

2011






Adjusted Operating Income





Operating income

$        51,666

$         5,440

$        87,841

$        33,479

Restructuring and other related charges

15,865

5,299

43,066

7,518

Charter acquisition-related expense

5,728

43,617

5,728

Fair value adjustments – ESAB/Howden backlog and inventory amortization expense

14,455

62,582

Asbestos coverage litigation expense

3,313

3,086

8,840

8,454

Adjusted operating income

$        85,299

$       19,553

$       245,946

$         55,179

Adjusted operating income margin

8.9%

11.5%

8.5%

10.7%

Adjusted Net Income and Adjusted Net Income Per Share





Net income (loss) attributable to Colfax Corporation

$          9,094

$        3,690

$   (84,138)

$     20,635

Restructuring and other related charges

15,865

5,299

43,066

7,518

Charter acquisition-related expense

5,728

43,617

5,728

Fair value adjustments – ESAB/Howden backlog and inventory amortization expense

14,455

62,582

Asbestos coverage litigation expense

3,313

3,086

8,840

8,454

Tax adjustment(1)

(2,025)

(4,575)

35,320

(7,118)

Adjusted net income

40,702

13,228

109,287

35,217

Adjusted net income margin

4.3%

7.8%

3.8%

6.8%

Dividends on preferred stock

5,072

13,879

Adjusted net income available to Colfax Corporation common shareholders

35,630

13,228

95,408

35,217

Less: net income attributable to participating securities(2)

4,582

12,256


$       31,048

$        13,228

$        83,152

$        35,217






Weighted-average shares outstanding—diluted

94,791,928

44,411,970

90,829,160

44,299,157

Adjusted net income per share

$           0.33

$           0.30

$           0.92

$           0.79






Net income (loss) per share — diluted (in accordance with GAAP)

$           0.04

$           0.08

$          (1.09)

$           0.47

(1) The effective tax rates used to calculate adjusted net income and adjusted net income per share are 25.3% and 29.0% for the third quarter and nine months ended September 28, 2012, respectively, and 31% for both the third quarter and nine months ended September 30, 2011.

(2) Adjusted net income per share was calculated consistently with the two-class method in accordance with GAAP as the Series A preferred stock are considered participating securities. Losses are not allocated to the preferred stock.

Colfax Corporation
Change in Sales, Orders and Backlog
Dollars in millions
(Unaudited)



Net Sales

Orders


$

%

$

%

Proforma for the three months ended September 30, 2011

$   971.7


$   451.2


Components of Change:





Existing businesses

49.5

5.1 %

18.0

4.0 %

Acquisitions

5.3

0.5 %

4.2

0.9 %

Foreign currency translation

(72.1)

(7.4)%

(29.6)

(6.5)%


(17.3)

(1.8)%

(7.4)

(1.6)%

For the three months ended September 28, 2012

$   954.4


$  443.8



Net Sales

Orders

 Backlog at
Period End


$

%

$

%

$

%

Proforma as of and for the nine months ended September 30, 2011

$ 2,789.3


$ 1,425.6


$ 1,348.2


Components of Change:







Existing businesses

228.7

8.2 %

44.4

3.1 %

70.0

5.2 %

Acquisitions

52.3

1.9 %

78.3

5.5  %

12.2

0.9 %

Foreign currency translation

(183.8)

(6.6)%

(72.6)

(5.1)%

(51.3)

(3.8)%


97.2

3.5 %

50.1

3.5 %

30.9

2.3 %

As of and for the nine months ended September 28, 2012

$ 2,886.5


$1,475.7


$1,379.1




CONTACT: Scott Brannan, Chief Financial Officer, Colfax Corporation, +1-301-323-9005, Scott.Brannan@colfaxcorp.com

Third Quarter 2012 Earnings Conference Call October 25, 2012

 
 

2 The following information contains forward - looking statements, including forward - looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward - looking statements include, but are not limited to, statements concerning Colfax's plans, objectives, expectations and intentions and other statements that are not historical or current facts. Forward - looking statements are based on Colfax's current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward - looking statements. Factors that could cause Colfax's results to differ materially from current expectations include, but are not limited to, factors detailed in Colfax's reports filed with the U.S. Securities and Exchange Commission including its 2011 Annual Report on Form 10 - K under the caption “Risk Factors”. In addition, these statements are based on a number of assumptions that are subject to change. This presentation speaks only as of this date. Colfax disclaims any duty to update the information herein. Forward - Looking Statements

 
 

3 3 Q3 2012 Results

 
 

4 Q3 2012 Highlights • Adjusted net income of $40.7 million ($0.33 per share) compared to $13.2 million ($0.30 per share) in Q3 2011, which includes a non - cash 3 cents per share gain related to adjustments to deferred tax balances • Net sales of $954.4 million, a decrease of 1.8% from Q3 2011 proforma net sales of $971.7 million; an organic increase of 5.1% • Adjusted operating income of $85.3 million compared to $19.6 million in Q3 2011 • Third quarter gas - and fluid - handling orders of $443.8 million compared to proforma orders of $451.2 million in Q3 2011, a decrease of 1.6%; an organic increase of 4.0% • Gas - and fluid - handling backlog of $1.4 billion at period end 4

 
 

5 Year to Date 2012 Highlights • Adjusted net income of $109.3 million ($0.92 per share) compared to $35.2 million ($0.79 per share) in Q3 2011 • Net sales of $2.9 billion, an increase of 3.5% from the nine months ended September 30, 2011 proforma net sales of $2.8 billion • Adjusted operating income of $245.9 million compared to $55.2 million in Q3 2011 • Gas - and fluid - handling orders of $1.5 billion compared to proforma orders of $1.4 billion in the nine months ended September 30, 2011, an increase of 3.5%; organic increase of 3.1% 5

 
 

6 6 Gas - and Fluid - Handling

 
 

7 Gas - and Fluid - Handling Q3 2012 Highlights • Net sales of $464.9 million compared to proforma net sales of $423.0 million in Q3 2011, an increase of 9.9%; an organic increase of 14.6% • Adjusted segment operating income of $51.7 million and adjusted segment operating income margin of 11.1% • Q3 2012 orders of $443.8 million compared to proforma orders of $451.2 million in Q3 2011, a decrease of 1.6%; an organic increase of 4.0% • Backlog of $1.4 billion at period end 7

 
 

8 Gas - and Fluid - Handling YTD 2012 Highlights • Net sales of $1.4 billion compared to proforma net sales of $1.2 billion in the nine months ended September 30, 2011, an increase of 13.0%; an organic increase of 14.4% • Adjusted segment operating income of $153.3 million and adjusted segment operating income margin of 11.1% • Orders of $1.5 billion compared to proforma orders of $1.4 billion the nine months ended September 30, 2011, an increase of 3.5%; an organic increase of 3.1% 8

 
 

9 Orders and Backlog 9 Orders (1) $451.2 $443.8 $1,425.6 $1,475.7 $0.0 $250.0 $500.0 $750.0 $1,000.0 $1,250.0 $1,500.0 Q3 2011 Q3 2012 YTD 2011 YTD 2012 Backlog (1) $0.0 $250.0 $500.0 $750.0 $1,000.0 $1,250.0 $1,500.0 Q3 2009Q4 2009Q1 2010Q2 2010Q3 2010Q4 2010Q1 2011Q2 2011Q3 2011Q4 2011Q1 2012Q2 2012Q3 2012 (1) Order and backlog data for the periods prior to Q2 2012 are presented on a proforma basis. __________________ Note: Dollars in millions (unaudited). QTD YTD Existing Businesses 4.0 % 3.1 % Acquisitions 0.9 % 5.5 % FX Translation (6.5)% (5.1)% Total Growth (1.6)% 3.5 % $1.35B $1.39B $1.38B

 
 

10 Revenue 10 Revenue (1) $423.0 $464.9 $1,226.7 $1,386.7 $0.0 $250.0 $500.0 $750.0 $1,000.0 $1,250.0 $1,500.0 Q3 2011 Q3 2012 YTD 2011 YTD 2012 (1) Q3 2011 and YTD 2011 sales are presented on a proforma basis. __________________ Note: Dollars in millions (unaudited). Aftermarket Revenue – YTD 2012 Foremarket 69% Aftermarket 31% Geographic Exposure – YTD 2012 Developed Economies 55% Emerging Markets 45% QTD YTD Existing Businesses 14.6 % 14.4 % Acquisitions 1.2 % 3.8 % FX Translation (5.9)% (5.2)% Total Growth 9.9 % 13.0 %

 
 

11 Q3 2012 Sales and Orders by End Market 11 Sales: $464.9 million Orders: $443.8 million Total Growth (Decline) Organic Growth (Decline) Power Generation 19.5 % 22.8 % Oil, Gas & Petrochemical 10.0 % 14.7 % Marine (16.5)% (10.7)% Mining 39.7 % 46.0 % General Industrial & Other 3.9 % 8.9 % Total 9.9 % 14.6 % Power Generation 33% Marine 14% Mining 8% Oil, Gas & Petro- chemical 20% General Industrial and Other 25% Total Growth (Decline) Organic Growth (Decline) Power Generation 8.5 % 10.6 % Oil, Gas & Petrochemical (16.4)% (9.9)% Marine (5.0)% 1.4 % Mining 11.4 % 23.8 % General Industrial & Other (1.2)% 5.5 % Total (1.6)% 4.0 % __________________ Note: Dollars in millions (unaudited). Total and organic growth (decline) is calculated on a proforma basis. Power Generation 32% Marine 11% Mining 10% Oil, Gas & Petro- chemical 24% General Industrial and Other 23%

 
 

12 YTD 2012 Sales and Orders by End Market 12 Sales: $1,386.7 million Orders: $1,475.7 million Total Growth (Decline) Organic Growth (Decline) Power Generation 20.0 % 22.1% Oil, Gas & Petrochemical 18.6 % 13.0% Marine (11.9)% (7.1)% Mining 36.3 % 43.0 % General Industrial & Other 7.2 % 10.6 % Total 13.0 % 14.4 % Total Growth (Decline) Organic Growth (Decline) Power Generation 16.4 % 18.5 % Oil, Gas & Petrochemical 0.6 % (12.4)% Marine (3.7)% 1.6 % Mining (3.1)% 4.8 % General Industrial & Other (3.2)% 0.2 % Total 3.5 % 3.1 % __________________ Note: Dollars in millions (unaudited). Total and organic growth (decline) is calculated on a proforma basis. Power Generation 31% Marine 12% Mining 9% Oil, Gas & Petro- chemical 25% General Industrial and Other 23% Power Generation 34% Marine 11% Mining 9% Oil, Gas & Petro- chemical 24% General Industrial and Other 22%

 
 

13 Power Generation Market Perspective 13 Sales & Orders Growth Q3 2012 vs. Q3 2011 YTD 2012 vs. YTD 2011 Total Organic Total Organic Sales 19.5% 22.8% 20.0% 22.1% Orders 8.5% 10.6% 16.4% 18.5% Colfax YTD 2012 Sales Split 31% Power Gen. Colfax YTD 2012 Orders Split Highlights ▪ Served by both Howden and Colfax Fluid Handling ▪ Driven by global fundamental undersupply of electricity ▪ Growth is strong in China, South Africa and South East Asia 34% Power Gen. __________________ Note: Total and organic growth (decline) is calculated on a proforma basis.

 
 

14 Oil, Gas & Petrochemical Market Perspective 14 Sales & Orders Growth (Decline) Colfax YTD 2012 Sales Split 25% OG&P Colfax YTD 2012 Orders Split 24% OG&P Highlights ▪ Served by both Howden and Colfax Fluid Handling ▪ National oil companies in Latin America and Russia expanding production and refinery capacity ▪ Thomassen compressor acquisition increases presence in this market __________________ Note: Total and organic growth (decline) is calculated on a proforma basis. Q3 2012 vs. Q3 2011 YTD 2012 vs. YTD 2011 Total Organic Total Organic Sales 10.0% 14.7% 18.6% 13.0% Orders (16.4)% (9.9)% 0.6% (12.4)%

 
 

15 Marine Market Perspective 15 Sales & Orders (Decline) Growth Colfax YTD 2012 Sales Split 12% Marine Colfax YTD 2012 Orders Split Highlights ▪ Comprised of commercial marine and government, or defense, customers ▪ Primarily served by Colfax Fluid Handling ▪ New ship build is down from 2011 peak ▪ Q3 orders strong for supply vessels 11% Marine __________________ Note: Total and organic growth (decline) is calculated on a proforma basis. Q3 2012 vs. Q3 2011 YTD 2012 vs. YTD 2011 Total Organic Total Organic Sales (16.5)% (10.7)% (11.9)% (7.1)% Orders (5.0)% 1.4% (3.7)% 1.6 %

 
 

16 Mining Market Perspective 16 Sales & Orders Growth (Decline) Colfax YTD 2012 Sales Split 9% Mining Colfax YTD 2012 Orders Split Highlights ▪ Primarily served by Howden ▪ Includes centrifugal and axial fans, providing mine ventilation ▪ Driven by demand of mined resources, including: coal, iron ore, copper, gold, nickel and potash ▪ Orders strong due to large North American orders in Q3 9% Mining __________________ Note: Total and organic growth (decline) is calculated on a proforma basis. Q3 2012 vs. Q3 2011 YTD 2012 vs. YTD 2011 Total Organic Total Organic Sales 39.7% 46.0% 36.3% 43.0% Orders 11.4% 23.8% (3.1)% 4.8%

 
 

17 General Industrial & Other Market Perspective 17 Sales & Orders Growth (Decline) Colfax YTD 2012 Sales Split 23% GI&O Colfax YTD 2012 Orders Split Highlights ▪ Includes both Howden and Colfax Fluid Handling ▪ Represents a variety of industrial fans and compressors, tunnel ventilation and pumps serving various industrial needs ▪ Sales and order growth was driven by industrial fans and compressors, particularly fans serving the steel industry 22% GI&O __________________ Note: Total and organic growth (decline) is calculated on a proforma basis. Q3 2012 vs. Q3 2011 YTD 2012 vs. YTD 2011 Total Organic Total Organic Sales 3.9% 8.9% 7.2% 10.6% Orders (1.2)% 5.5% (3.2)% 0.2%

 
 

18 18 Fabrication Technology

 
 

19 Fabrication Technology Q3 2012 Highlights • Net sales of $489.6 million compared to proforma net sales of $548.8 million in Q3 2011, a decrease of 10.8%; an organic decline of 2.2% • Adjusted segment operating income of $43.9 million and adjusted operating income margin of 9.0% • Tight cost control and improved pricing drove margin improvement • Continued sequential margin improvement in India despite challenging economic environment • Revenue and operating income negatively impacted by the start up of a new consumables facility in the U.S. 19

 
 

20 Fabrication Technology YTD 2012 Highlights • Net sales of $1.5 billion, a decrease of 4.0% compared to proforma YTD Q3 2011 sales; an organic increase of 3.3% • Adjusted segment operating income of $123.2 million and adjusted operating income margin of 8.2% • Higher consumable volumes in North America, the Middle East and South America 20

 
 

21 Revenue 21 Revenue (1) $548.8 $489.6 $1,562.5 $1,449.8 $0.0 $200.0 $400.0 $600.0 $800.0 $1,000.0 $1,200.0 $1,400.0 $1,600.0 Q3 2011 Q3 2012 YTD 2011 YTD 2012 (1) Q3 2011 and YTD 2011 sales are presented on a proforma basis. __________________ Note: Dollars in millions (unaudited). Revenue – YTD 2012 Equipment 26% Consumables 74% Geographic Exposure – YTD 2012 Developed Economies 42% Emerging Markets 58% QTD YTD Volume (0.8)% 2.2% Price/Mix (1.4)% 1.1% Acquisitions 0.0 % 0.4% FX Translation (8.6)% (7.7)% Total Decline (10.8)% (4.0)%

 
 

22 22 Results of Operations

 
 

23 Income Statement Summary (unaudited) 23 Refer to Appendix for Non - GAAP reconciliation and footnotes. __________________ Note: Dollars in millions, except per share amounts Three Months Ended September 28, 2012 September 30, 2011 Net sales $ 954.4 $ 170.3 Gross profit $ 288.0 $ 60.7 % of sales 30.2% 35.6% SG&A expense $ 217.1 $ 41.1 % of sales 22.7% 24.1% Adjusted operating income $ 85.3 $ 19.6 % of sales 8.9% 11.5% Adjusted net income $ 40.7 $ 13.2 % of sales 4.3% 7.8% Adjusted net income per share $ 0.33 $ 0.30

 
 

24 Income Statement Summary (unaudited) 24 Refer to Appendix for Non - GAAP reconciliation and footnotes. __________________ Note: Dollars in millions, except per share amounts Nine Months Ended September 28, 2012 September 30, 2011 Net sales $ 2,886.5 $ 515.6 Gross profit $ 844.6 $ 178.6 % of sales 29.3% 34.6% SG&A expense $ 661.2 $ 123.4 % of sales 22.9% 23.9% Adjusted operating income $ 245.9 $ 55.2 % of sales 8.5% 10.7% Adjusted net income $ 109.3 $ 35.2 % of sales 3.8% 6.8% Adjusted net income per share $ 0.92 $ 0.79

 
 

25 25 Appendix

 
 

26 Disclaimer 26 Colfax has provided financial information that has not been prepared in accordance with GAAP. These non - GAAP financial measures are adjusted net income, adjusted net income per share, projected adjusted net income per share, adjusted operating income, organic sales growth (decline) and organic order growth (decline). Adjusted net income, adjusted net income per share, projected adjusted net income per share and adjusted operating income exclude asbestos coverage litigation expense, expenses related to major restructuring programs or any additional structural changes announced in the future, expenses related to the Charter acquisition and significant year - one fair value adjustment amortization expense. The effective tax rates used to calculate adjusted net income and adjusted net income per share are 25.3% and 29.0% for the third quarter and nine months ended September 28, 2012, respectively, and 31% for both the third quarter and nine months ended September 30, 2011. Projected adjusted earnings per share was calculated using a 30% effective tax rate for the fourth quarter of 2012. Organic sales growth (decline) and organic order growth (decline) exclude the impact of bolt - on acquisitions and foreign exchange rate fluctuations and are presented on a proforma basis (the proforma comparison includes the 2011 sales and orders for Howden and ESAB, excluding the first 12 days of the year to date reporting period). These non - GAAP financial measures assist Colfax in comparing its operating performance on a consistent basis because, among other things, they remove the impact of asbestos insurance coverage issues, costs related to the Charter acquisition, major restructuring programs and items outside the control of its operating management. Sales and order information by end market are estimates. We periodically update our customer groupings order to refine these estimates.

 
 

27 Non - GAAP Reconciliation (unaudited) ____________________ Note: Dollars in thousands, except per share amounts. (1) The effective tax rates used to calculate adjusted net income and adjusted net income per share are 25.3% and 29% for the thi rd quarter and nine months ended September 28, 2012, respectively, and 31% for both the third quarter and nine months ended September 30, 2011. (2) Adjusted net income per share was calculated consistent with the two - class method in accordance with GAAP as the Series A prefer red stock are considered participating securities. Losses are not allocated to the preferred stock. September 28, 2012 September 30, 2011 September 28, 2012 September 30, 2011 Adjusted Net Income and Adjusted Earnings Per Share Net income (loss) attributable to Colfax Corporation 9,094$ 3,690$ (84,138)$ 20,635$ Restructuring and other related charges 15,865 5,299 43,066 7,518 Charter acquisition-related expense - 5,728 43,617 5,728 Fair value adjustments - ESAB/Howden backlog and inventory amortization expense 14,455 - 62,582 - Asbestos coverage litigation expense 3,313 3,086 8,840 8,454 Tax adjustment (1) (2,025) (4,575) 35,320 (7,118) Adjusted net income 40,702 13,228 109,287 35,217 Adjusted net income margin 4.3% 7.8% 3.8% 6.8% Dividends on preferred stock 5,072 - 13,879 - Adjusted net income available to Colfax Corporation common shareholders 35,630 13,228 95,408 35,217 Less: net income attributable to participating securities (2) 4,582 - 12,256 - 31,048$ 13,228$ 83,152$ 35,217$ Weighted-average shares outstanding - diluted 94,791,928 44,411,970 90,829,160 44,299,157 Adjusted net income per share 0.33$ 0.30$ 0.92$ 0.79$ Net income (loss) per share— basic and diluted (in accordance with GAAP) 0.04$ 0.08$ (1.09)$ 0.47$ Nine Months EndedThree Months Ended

 
 

28 Non - GAAP Reconciliation (unaudited) ____________________ Note: Dollars in thousands. Net sales -$ -$ Operating income 32,361 7.0% 31,357 6.4% (12,052) 51,666 5.4% 15,471 9.1% (10,031) 5,440$ 3.2% Charter acquisition-related expense - - - - - 5,728 5,728 Restructuring and other related charges 1,564 12,498 1,803 15,865 5,299 - 5,299 Asbestos coverage litigation expense 3,313 - - 3,313 3,086 - 3,086 Fair value adjustments - ESAB/Howden backlog and inventory amortization expense 14,455 - - 14,455 - - - Adjusted operating income 51,693 11.1% 43,855 9.0% (10,249) 85,299 8.9% 23,856$ 14.0% (4,303)$ 19,553$ 11.5% Q3 2012 Q3 2011 Gas and Fluid Handling Fabrication Technology Corporate and Other Total Colfax Corporation Corporate and Other Total Colfax CorporationFluid Handling 954,440$ 170,294$ 170,294$ 464,873$ 489,567$

 
 

29 Non - GAAP Reconciliation (unaudited) ____________________ Note: Dollars in thousands. Net sales -$ -$ Operating income 93,467 6.7% 74,642 5.0% (80,268) 87,841 3.0% 54,861$ 10.6% (21,382)$ 33,479$ 6.5% Charter acquisition-related expense - - 43,617 43,617 - 5,728 5,728 Restructuring and other related charges 5,379 31,620 6,067 43,066 6,469 1,049 7,518 Asbestos coverage litigation expense 8,840 - - 8,840 8,454 - 8,454 Fair value adjustments - ESAB/Howden backlog and inventory amortization expense 45,597 16,985 - 62,582 - - - Adjusted operating income 153,283 11.1% 123,247 8.2% (30,584) 245,946 8.5% 69,784$ 13.5% (14,605)$ 55,179$ 10.7% YTD Q3 2012 Total Colfax Corporation Fluid Handling YTD Q3 2011 Total Colfax Corporation Corporate and Other Gas and Fluid Handling Fabrication Technology Corporate and Other 1,386,699$ 1,499,760$ 2,886,459$ 515,601$ 515,601$

 
 

30 Sales & Order Growth (unaudited) ____________________ Note: Dollars in millions. $ % $ % Proforma for the three months ended September 30, 2011 971.7$ 451.2$ Components of Change: Existing Businesses 49.5 5.1 % 18.0 4.0 % Acquisitions 5.3 0.5 % 4.2 0.9 % Foreign Currency Translation (72.1) (7.4)% (29.6) (6.5)% Total (17.3) (1.8)% (7.4) (1.6)% For the three months ended September 28, 2012 954.4$ 443.8$ $ % $ % $ % Proforma as of and for the nine months ended September 30, 2011 2,789.3$ 1,425.6$ 1,348.2$ Components of Change: Existing Businesses 228.7 8.2 % 44.4 3.1 % 70.0 5.2 % Acquisitions 52.3 1.9 % 78.3 5.5 % 12.2 0.9 % Foreign Currency Translation (183.8) (6.6)% (72.6) (5.1)% (51.3) (3.8)% Total 97.2 3.5 % 50.1 3.5 % 30.9 2.3 % As of and for the nine months ended September 28, 2012 2,886.5$ 1,475.7$ 1,379.1$ Sales Orders Backlog Sales Orders

 
 

31 Balance Sheet (unaudited) September 28, December 31, 2012 2011 ASSETS CURRENT ASSETS: Cash and cash equivalents $ 517,343 $ 75,108 Tradereceivables,lessallowancefordoubtfulaccountsof$8,920 and $2,578 882,867 117,475 Inventories, net 519,358 56,136 Other current assets 313,948 102,489 Total current assets 2,233,516 351,208 Property, plant and equipment, net 662,294 90,939 Goodwill 1,929,436 204,844 Intangible assets, net 745,583 41,029 Other assets 484,895 400,523 Total assets $ 6,055,724 $ 1,088,543 LIABILITIES AND SHAREHOLDERS’ EQUITY CURRENT LIABILITIES: Current portion of long-term debt $ 34,033 $10,000 Accounts payable 636,521 54,035 Accrued liabilities 550,060 176,007 Total current liabilities 1,220,614 240,042 Long-term debt, less current portion 1,659,070 101,518 Other liabilities 996,343 557,708 Total liabilities 3,876,027 899,268 Equity: Preferred stock, $0.001 par value; 20,000,000 and 10,000,000 shares authorized; 13,877,552 and none issued and outstanding 14 — Commonstock,$0.001parvalue;400,000,000and200,000,000 shares authorized; 93,977,842 and 43,697,570 issued and outstanding 94 44 Additional paid-in capital 2,191,064 415,527 Accumulated deficit (153,520) (55,503) Accumulated other comprehensive loss (81,141) (170,793) Total Colfax Corporation equity 1,956,511 189,275 Noncontrolling interest 223,186 — Total equity 2,179,697 189,275 Total liabilities and equity $ 6,055,724 $ 1,088,543

 
 

32 2012 Outlook Summary (October Update) Note: Guidance as of 10/25/12 In thousands, except per share data Revenue- Base Business 994,000$ 1,040,000$ Acquired Entities 20,000 24,000 Revenue 1,014,000$ 1,064,000$ 3,900,000$ 3,950,000$ Adjusted Operating Profit 95,000 101,700 340,900 347,600 Interest (23,000) (23,000) (91,300) (91,300) Taxes (21,600) (23,600) (73,100) (75,100) Noncontrolling interest (5,100) (5,400) (21,900) (22,200) Adjusted Net Income- Colfax 45,300 49,700 154,600 159,000 Preferred Dividends (5,100) (5,100) (19,000) (19,000) Adjusted Net Income Available to Colfax 40,200 44,600 135,600 140,000 Adjusted EPS 0.37$ 0.41$ 1.29$ 1.33$ Q4 2012

 
 

33 Non - GAAP Reconciliation (unaudited) Projected net loss per share - diluted $ 0.15 $ 0.19 $ (0.98) $ (0.94) Participating shares adjustment - - 0.13 0.13 Fair value adjustments - Charter inventory and backlog 0.15 0.15 0.78 0.78 Restructuring costs 0.07 0.07 0.48 0.48 Asbestos coverage litigation 0.02 0.02 0.11 0.11 Charter transaction costs - - 0.44 0.44 Tax adjustment (0.02) (0.02) 0.33 0.33 Projected adjusted net income per share - diluted $ 0.37 $ 0.41 $ 1.29 $ 1.33 2012 EPS Range Q4 Note: Guidance as of 10/25/12